当前位置: X-MOL 学术J. Natl. Cancer Inst. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Response to Di Cosimo, Torri, and Porcu.
Journal of the National Cancer Institute ( IF 9.9 ) Pub Date : 2019-11-01 , DOI: 10.1093/jnci/djz095
Elisabeth Trapp 1, 2 , Wolfgang Janni 3 , Christian Schindlbeck 4 , Julia Jückstock 1 , Ulrich Andergassen 1 , Amelie deGregorio 3 , Marianna Alunni-Fabbroni 1 , Marie Tzschaschel 3 , Arkadius Polasik 3 , Julian G Koch 1 , Thomas W P Friedl 3, 5 , Peter A Fasching 6 , Lothar Haeberle 6 , Tanja Fehm , Andreas Schneeweiss 7 , Matthias W Beckmann 6 , Klaus Pantel 8 , Volkmar Mueller 9 , Brigitte Rack 3 , Christoph Scholz 3
Affiliation  

We are grateful to Di Cosimo, Torri, and Porcu for their valuable comment on our article. We showed that the presence of circulating tumor cells (CTCs) as assessed 2 years after chemotherapy was prognostic for poor disease-free survival (DFS) and overall survival (OS). Di Cosimo et al. raise the question of clinical relevance of this finding by recalculating positive and negative predictive values for a 0- to 40-month interval.

中文翻译:

对Di Cosimo,Torri和Porcu的回应。

我们感谢Di Cosimo,Torri和Porcu对我们的文章提出了宝贵的意见。我们显示,化疗后2年评估的循环肿瘤细胞(CTC)的存在可预示不良的无病生存期(DFS)和总体生存期(OS)。Di Cosimo等。通过在0到40个月的时间间隔内重新计算阳性和阴性预测值,提出了这一发现与临床相关性的问题。
更新日期:2019-06-11
down
wechat
bug